These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
52 related items for PubMed ID: 8352800
1. Inhibitory effect of arachidonic acid on GTPase activating protein is antagonized by 1-stearoyl, 2-arachidonoyl glycerol. Homayoun P, Stacey DW. Biochem Biophys Res Commun; 1993 Aug 16; 194(3):1413-9. PubMed ID: 8352800 [Abstract] [Full Text] [Related]
2. Inhibitory effect of arachidonic acid on GTPase activating protein is antagonized by 1-stearoyl, 2-arachidonoyl glycerol. Homayoun P, Stacey DW. Biochem Biophys Res Commun; 1993 Aug 31; 195(1):144-50. PubMed ID: 8363595 [Abstract] [Full Text] [Related]
3. Linear free energy relationships in the intrinsic and GTPase activating protein-stimulated guanosine 5'-triphosphate hydrolysis of p21ras. Schweins T, Geyer M, Kalbitzer HR, Wittinghofer A, Warshel A. Biochemistry; 1996 Nov 12; 35(45):14225-31. PubMed ID: 8916907 [Abstract] [Full Text] [Related]
4. Complex formation between the p21ras GTPase-activating protein and phosphoproteins p62 and p190 is independent of p21ras signalling. Pronk GJ, de Vries-Smits AM, Ellis C, Bos JL. Oncogene; 1993 Oct 12; 8(10):2773-80. PubMed ID: 8378086 [Abstract] [Full Text] [Related]
5. Stimulation of ras GTPase activity by an anti-ras monoclonal antibody. Agellon S, Stone JC. Mol Carcinog; 1996 Jul 12; 16(3):132-8. PubMed ID: 8688148 [Abstract] [Full Text] [Related]
6. Conformational transitions in p21ras and in its complexes with the effector protein Raf-RBD and the GTPase activating protein GAP. Geyer M, Schweins T, Herrmann C, Prisner T, Wittinghofer A, Kalbitzer HR. Biochemistry; 1996 Aug 13; 35(32):10308-20. PubMed ID: 8756686 [Abstract] [Full Text] [Related]
7. Mechanistic analysis of the observed linear free energy relationships in p21ras and related systems. Schweins T, Warshel A. Biochemistry; 1996 Nov 12; 35(45):14232-43. PubMed ID: 8916908 [Abstract] [Full Text] [Related]
8. Proliferation and differentiation of PC12 cells were affected by p21ras GTPase activating proteins and its deletion mutant proteins. Nakata H, Watanabe Y. Biochem Biophys Res Commun; 1996 Jan 17; 218(2):538-43. PubMed ID: 8561792 [Abstract] [Full Text] [Related]
9. A yeast GTPase-activating protein that interacts specifically with a member of the Ypt/Rab family. Strom M, Vollmer P, Tan TJ, Gallwitz D. Nature; 1993 Feb 25; 361(6414):736-9. PubMed ID: 8441469 [Abstract] [Full Text] [Related]
10. Control of ras activation. Downward J. Cancer Surv; 1996 Feb 25; 27():87-100. PubMed ID: 8909796 [Abstract] [Full Text] [Related]
11. CD4 ligands inhibit the formation of multifunctional transduction complexes involved in T cell activation. Jabado N, Pallier A, Le Deist F, Bernard F, Fischer A, Hivroz C. J Immunol; 1997 Jan 01; 158(1):94-103. PubMed ID: 8977179 [Abstract] [Full Text] [Related]
12. The effect of GTPase activating protein upon ras is inhibited by mitogenically responsive lipids. Tsai MH, Yu CL, Wei FS, Stacey DW. Science; 1989 Jan 27; 243(4890):522-6. PubMed ID: 2536192 [Abstract] [Full Text] [Related]
13. Differences in the interaction of p21c-Ha-ras-GMP-PNP with full-length neurofibromin and GTPase-activating protein. DiBattiste D, Golubic M, Stacey D, Wolfman A. Oncogene; 1993 Mar 27; 8(3):637-43. PubMed ID: 8437847 [Abstract] [Full Text] [Related]
14. Regulation of Ras-GAP and the neurofibromatosis-1 gene product by eicosanoids. Han JW, McCormick F, Macara IG. Science; 1991 Apr 26; 252(5005):576-9. PubMed ID: 1902323 [Abstract] [Full Text] [Related]
15. Determinants of Ras proteins specifying the sensitivity to yeast Ira2p and human p120-GAP. Parrini MC, Bernardi A, Parmeggiani A. EMBO J; 1996 Mar 01; 15(5):1107-11. PubMed ID: 8605880 [Abstract] [Full Text] [Related]
16. What is the role of the helical domain of Gsalpha in the GTPase reaction? Shnerb T, Lin N, Shurki A. Biochemistry; 2007 Sep 25; 46(38):10875-85. PubMed ID: 17727271 [Abstract] [Full Text] [Related]
17. Hyperactive Ras as a therapeutic target in neurofibromatosis type 1. Weiss B, Bollag G, Shannon K. Am J Med Genet; 1999 Mar 26; 89(1):14-22. PubMed ID: 10469432 [Abstract] [Full Text] [Related]
18. Characterization of Ras effector mutant interactions with the NF1-GAP related domain. Marshall MS, Hettich LA. Oncogene; 1993 Feb 26; 8(2):425-31. PubMed ID: 8426748 [Abstract] [Full Text] [Related]
19. ras effector loop mutations that dissociate p120GAP and neurofibromin interactions. Stang S, Bottorff D, Stone JC. Mol Carcinog; 1996 Jan 26; 15(1):64-9. PubMed ID: 8561868 [Abstract] [Full Text] [Related]
20. Ras-GTPase activating protein inhibition specifically induces apoptosis of tumour cells. Leblanc V, Delumeau I, Tocqué B. Oncogene; 1999 Aug 26; 18(34):4884-9. PubMed ID: 10490822 [Abstract] [Full Text] [Related] Page: [Next] [New Search]